Clinical Study

Evaluating the Contributions of Dynamic Flow to Freezing of Gait in Parkinson's Disease

Table 1

Characteristics of the three groups.

GroupAge-M (years)Height-M (cm)UPDRS-M (score)Years since diagnosed-M (years)Dose of Levodopa-M (mg)Gender

PD FOG72.4 (6.69)172.51 (8.51)32.8 (7.34)9.07 (5.29)1013.33 (390.27)13 males, 2 females
PD Non-FOG72.19 (6.23)170.66 (9.69)28.81 (6.35)5.97 (4.61)725.0 (449.81)10 males, 6 females
HC70.75 (5.98)167.96 (7.53) 6 males, 10 females

Note: M denotes mean, standard deviations found in brackets.